Showing papers by "Marc Schindewolf published in 2015"
TL;DR: The data do not support a preference of younger patients for thrombophilia testing after a first venous thromboembolic event, and an increased risk of recurrence for a heterozygous factor V Leiden mutation only in young females without hormonal treatment whereas the predictive value of a heter allele was restricted to males over the age of 40 years.
Abstract: Background: Whether screening for thrombophilia is useful for patients after a first episode of venous thromboembolism (VTE) is a controversial issue However, the impact of thrombophilia
9 citations
3 citations